Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Pharmaceutical Dissolution of Gallstones

JAMA. 1983;250(17):2373-2374. doi:10.1001/jama.1983.03340170095041.
Text Size: A A A
Published online


BILIARY tract disease is the fifth leading cause of hospitalization, and 500,000 cholecystectomies are performed each year in the United States. An estimated 20 million persons have either symptomatic or asymptomatic gallstone disease. One million patients with gallstones are discovered each year. The femaleto-male ratio of gallstone disease is 3:1, and the incidence in females in some reports is up to 70%. The cost of gallstone disease in the United States is greater than $1 billion per year. Before 1969, therapy for gallstone disease consisted entirely of surgical procedures. Since then, the promise of dissolution of gallstones has been attended with great interest. Thus, a report from the Council on Scientific Affairs of the status of this new therapy is considered desirable.

Brief Report  A large cooperative study, the National Cooperative Gallstone Study, involved 16 medical centers in the randomized treatment of 916 patients with radiolucent gallstones with either 375


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.